#HIVResists Policy Update: Resistance in the Face of Attacks on Our Communities
Positive Women's Network of the United States of America; Posted Mar 1, 12:39 p.m. ET
From cabinet nominations to sexual and reproductive rights to immigration, check out PWN-USA's monthly federal and state policy roundups.
Russia: Government to Examine Possibility of Removing HIV-Specific Criminal Law and Broadening Prosecutions to All Serious Communicable Diseases Under General 'Bodily Harm' Laws
Edwin J. Bernard, HIV Justice Network; Posted Mar 1, 11:47 a.m. ET
The high-level discussion on removing Russia's HIV-specific criminal law is taking place at the same time as a number of other policy decisions relating to HIV.
Baring a Bit of My Heart to Share My Journey to Sobriety
Charles Sanchez, TheBody.com; Posted Feb 28, 5:11 p.m. ET
No one would call Charles Sanchez bashful. But getting sober was deeply personal, and happened in a quiet, tender place inside him. Here's what happened when he chose to share this journey on video.
Dolutegravir Monotherapy Studies Halted Due to Integrase Resistance: Dual Therapy Studies Continue
Simon Collins, HIV i-Base; Posted Feb 28, 4:06 p.m. ET
Several studies at CROI 2017 reported a similar conclusion: reducing ART to dolutegravir monotherapy should be stopped.
Everyone living with HIV has a story to tell. Find out how to share your own experiences in one or both of the series below, which feature the writings of readers like you.
Regardless of where or how it happened, the day you received your HIV-positive diagnosis was likely among the most intense days you'll ever live through. Some of TheBody.com's readers have generously shared their experiences -- to reflect on how they've changed, and so that others would know that they too can survive, and even thrive, following that fateful day. How did you get through it?
Many types of medications can save or improve lives, but they can also have unintended consequences. For some people living with HIV, taking meds can be a complicated cycle -- and for others, a Sunday stroll. Medication side effects can be mild or life altering, horrible or even pleasurable; some people living with HIV never experience any at all. It seems like everyone's got a story about side effects. What's yours?
Adverse Pregnancy Outcomes and Risk Factors in the PROMISE Trial
Polly Clayden, HIV i-Base; Posted Feb 28, 3:54 p.m. ET
While antiretroviral therapy in pregnancy reduced vertical transmission, it also increased the frequency of several adverse birth outcomes compared with antenatal zidovudine (AZT) alone.
Being Underweight or Obese Tied to Serious Non-AIDS Illnesses in D:A:D Study
Mark Mascolini, TheBodyPRO.com; Posted Feb 28, 3:25 p.m. ET
Low body mass index and obesity, but not being overweight, predicted mortality and serious non-AIDS events, including cardiovascular disease and cancers, in a 41,149-person D:A:D study analysis.
Utah House Committee: Sex Without HIV Disclosure Is 'Nonconsensual'
JD Davids, TheBody.com; Posted Feb 28, 2:34 p.m. ET
Utah's House Judiciary Committee voted to expand the definition of "nonconsensual sex" to include nondisclosure of HIV status and to increase penalties for other offenses solely based on HIV status.
Classic Risk Factors Drive Heart Attack Rates More Than HIV Variables
Mark Mascolini, TheBodyPRO.com; Posted Feb 27, 6:59 p.m. ET
Avoiding traditional cardiovascular risk factors -- high total cholesterol, hypertension and smoking -- would have the biggest impact on cutting myocardial infarction (MI) rates in North Americans with HIV.
My Health Tracker can help you organize your HIV treatment information privately and securely in one place. This way, you can take better charge over your health, and you and your doctor can have even more productive conversations about your treatment.
Registration takes only a couple of minutes, requires no personal info, and you'll be able to pick up where you left off at any time.
HIV Vaccine Plus Latency Reactivator Induces Sustained HIV Remission in Proof-of-Concept Study
Mark Mascolini, TheBodyPRO.com; Posted Feb 27, 6:51 p.m. ET
Two doses of a therapeutic HIV vaccine plus three infusions of romidepsin, an HIV latency reactivator, allowed five of 13 trial participants to stay off antiretroviral therapy without rebound for up to 28 weeks in a Spanish proof-of-concept study.
Improving Outcomes With ID Consultation: Three More Papers for the Collection
Paul E. Sax, M.D., Journal Watch; Posted Feb 27, 4:07 p.m. ET
A colleague of Paul Sax, M.D., once posed the question, "Why do ID specialists even exist?" Saying, "There is nothing we do that other doctors couldn't also do, provided they had the motivation."
What's Your Message to the Trump Administration About the Fight Against HIV?
Warren Tong, TheBodyPRO.com; Posted Feb 27, 2:59 p.m. ET
We asked care providers, researchers and community leaders what their message to the Trump administration would be regarding the fight against HIV.
South Africa Launches Clinical Trial to Cut Heart Disease in HIV-Positive People
Candice Bailey, The Conversation; Posted Feb 27, 1:37 p.m. ET
Scientists are embarking on a massive clinical trial to test a drug to reduce the chances of people living with HIV developing heart disease.
>> Browse Older Featured Stories